Response: pure red blood cell aplasia: association with large granular lymphocyte leukemia and the prognostic value of cytogenetic abnormalities.
Tefferi
A
A
Lacy
M Q
MQ
Kurtin
P J
PJ
D003520:Cyclophosphamide / Q000009:adverse effects / Q000627:therapeutic use; D016572:Cyclosporine / Q000009:adverse effects / Q000627:therapeutic use; D015329:Gene Rearrangement, T-Lymphocyte; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000494:pharmacology*; D015459:Leukemia-Lymphoma, Adult T-Cell / Q000209:etiology* / Q000235:genetics; D011289:Preleukemia / Q000188:drug therapy / Q000235:genetics / Q000473:pathology; D011379:Prognosis; D012010:Red-Cell Aplasia, Pure / Q000188:drug therapy / Q000235:genetics / Q000473:pathology
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D003520:Cyclophosphamide